Literature DB >> 7707623

HIV seroprevalence in injection drug users.

J K Watters, R N Bluthenthal, A H Kral.   

Abstract

Mesh：

Year:  1995        PMID： 7707623

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  12 in total

1.  HIV prevalence, risk behaviors, health care use, and mental health status of transgender persons: implications for public health intervention.

Authors:  K Clements-Nolle; R Marx; R Guzman; M Katz
Journal:  Am J Public Health       Date:  2001-06       Impact factor: 9.308

2.  HIV seroprevalence among homeless and marginally housed adults in San Francisco.

Authors:  Marjorie J Robertson; Richard A Clark; Edwin D Charlebois; Jacqueline Tulsky; Heather L Long; David R Bangsberg; Andrew R Moss
Journal:  Am J Public Health       Date:  2004-07       Impact factor: 9.308

3.  Assessment of HIV testing of urban injection drug users: implications for expansion of HIV testing and prevention efforts.

Authors:  Robert Heimer; Lauretta E Grau; Erin Curtin; Kaveh Khoshnood; Merrill Singer
Journal:  Am J Public Health       Date:  2006-11-30       Impact factor: 9.308

4.  Community characteristics associated with HIV risk among injection drug users in the San Francisco Bay Area: a multilevel analysis.

Authors:  Ricky N Bluthenthal; D Phuong Do; Brian Finch; Alexis Martinez; Brian R Edlin; Alex H Kral
Journal:  J Urban Health       Date:  2007-07-27       Impact factor: 3.671

5.  IL28B rs12979860 genotype and spontaneous clearance of hepatitis C virus in a multi-ethnic cohort of injection drug users: evidence for a supra-additive association.

Authors:  Fatma M Shebl; Ruth M Pfeiffer; Dianna Buckett; Brian Muchmore; Sabrina Chen; Myhanh Dotrang; Ludmila Prokunina-Olsson; Brian R Edlin; Thomas R O'Brien
Journal:  J Infect Dis       Date:  2011-10-19       Impact factor: 5.226

6.  Implementing an HIV Rapid Testing-Linkage-to-Care Project Among Homeless Individuals in Los Angeles County: A Collaborative Effort Between Federal, County, and City Government.

Authors:  Henry D Anaya; Jaimi N Butler; Herschel Knapp; Kee Chan; Erin E Conners; Sophia F Rumanes
Journal:  Am J Public Health       Date:  2015-01       Impact factor: 9.308

7.  Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearance.

Authors:  Thomas R O'Brien; Ruth M Pfeiffer; Ashley Paquin; Krystle A Lang Kuhs; Sabrina Chen; Herbert L Bonkovsky; Brian R Edlin; Charles D Howell; Gregory D Kirk; Mark H Kuniholm; Timothy R Morgan; Howard D Strickler; David L Thomas; Ludmila Prokunina-Olsson
Journal:  J Hepatol       Date:  2015-07-15       Impact factor: 25.083

8.  Reasons for assisting with injection initiation: Results from a large survey of people who inject drugs in Los Angeles and San Francisco, California.

Authors:  Kelsey A Simpson; Alex H Kral; Jesse L Goldshear; Lynn Wenger; Carol S Strike; Ricky N Bluthenthal
Journal:  Drug Alcohol Depend       Date:  2020-02-05       Impact factor: 4.492

9.  Preventing HIV in injection drug users: choosing the best mix of interventions for the population.

Authors:  Amy R Wilson; James G Kahn
Journal:  J Urban Health       Date:  2003-09       Impact factor: 3.671

10.  Spatial distribution of HIV prevalence and incidence among injection drugs users in St Petersburg: implications for HIV transmission.

Authors:  Robert Heimer; Russell Barbour; Alla V Shaboltas; Irving F Hoffman; Andrei P Kozlov
Journal:  AIDS       Date:  2008-01-02       Impact factor: 4.177
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.